Biopharmaceutical research companies have been and continue to be a source of jobs, tax revenue, and research spending in Pennsylvania.

This report shows how biopharmaceutical research companies continue to be vitally important to the economy and patient health in Pennsylvania.

Since 2004, biopharmaceutical research companies are conducting or have conducted more than 7,800 clinical trials of new medicines in Pennsylvania in collaboration with clinical research centers and hospitals. These clinical trials have investigated or are investigating some of Pennsylvania’s biggest health care challenges, including asthma, arthritis, cancer, diabetes, cardiovascular disease and Alzheimer’s disease.